Arrhythmia Research Technology (HRT) Widens Q2 Loss to 37c/Share
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Selling and marketing: 303.28K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Selling and marketing: 303.28K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Arrhythmia Research Technology (AMEX: HRT) reported Q2 EPS of ($0.37), versus ($0.09) reported last year. Revenue for the quarter came in at $4.98 million, versus $6.02 million reported last year.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- DA Davidson Reiterates Neutral Rating on Brunswick Corp (BC)
- DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
